Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 27 Mar 2024
An interdisciplinary team at the University of Waterloo has created a novel material for contact lenses that has the potential to release medications in a controlled manner to promote faster healing of corneal wounds and function as a bandage. A study providing an overview.
Read Full NewsThe recommendation follows phase 3 data showing longer progression-free survival when patients switched to camizestrant plus a CDK4/6 inhibitor.
The antibody drug conjugate was approved by the FDA for certain patients with triple-negative breast cancer.
1.
Nuclear missile workers are contracting cancer: They blame the bases
2.
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants
3.
New analysis helps discern benign from malignant thyroid growths
4.
MCh in Gynecologic Oncology: Admission, Medical School, Fees, Qualifications Information
5.
Even a few mutated cells can significantly impact how blood cancers develop, study finds
1.
Uncovering the Hidden Signs: How to Recognize the Early Symptoms of Colon Cancer
2.
The benefits and risks of taking fludrocortisone for adrenal insufficiency
3.
IGSF8: A Rising Star in Cancer Immunotherapy - Harnessing the Innate Immune System
4.
Innovative Intraoperative Therapies in Neurosurgical Oncology: Advancing Precision and Outcomes
5.
Different Types of Blood Dyscrasias
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An In-Depth Look At The Signs And Symptoms Of Lymphoma
2.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Further Discussion on A New Perspective
3.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
4.
Virtual Case Study on Pedal Edema and Triple Vessel Disease - An Initiative by Hidoc Dr.
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge